91 filings
Page 2 of 5
8-K
2lbwg8c jz
6 Apr 20
Regulation FD Disclosure
2:21pm
8-K
ppdrynd9vgq8hlr84o9n
1 Apr 20
Innovation Pharmaceuticals Receives Data Supporting Brilacidin’s Direct Inhibition of SARS-CoV-2, the Novel Coronavirus Responsible for COVID-19
12:00pm
8-K
z50dl shpuiqo
6 Mar 20
Innovation Pharmaceuticals Signs Second MTA to Explore Brilacidin as Coronavirus
12:00pm
8-K
a6vyz lqg2u1a77vbf
27 Feb 20
Regulation FD Disclosure
12:00pm
8-K
j1pn5 tsw7qrevf3
13 Feb 20
Innovation Pharmaceuticals Phase 1 Trial of Brilacidin for Ulcerative Colitis Meets Primary Endpoints; Positive Topline Results of Oral Brilacidin
4:05pm
8-K
c6zetn7xsyp
26 Dec 19
Entry into a Material Definitive Agreement
5:16pm
8-K
5wrr3mcj
24 Dec 19
Departure of Directors or Certain Officers
12:00am
8-K
kgjn7se om
20 Sep 19
Amendments to Articles of Incorporation or Bylaws
4:33pm
8-K
jpvmzn 82
22 Jul 19
Entry into a Material Definitive Agreement
9:30am
8-K
ozoe10t6b1spqe3pebbi
16 May 19
Regulation FD Disclosure
10:15am
8-K
q65094 mo
10 May 19
Entry into a Material Definitive Agreement
7:32am
8-K
l9ls3z62 nt7zg
31 Jan 19
Regulation FD Disclosure
4:15pm
8-K
piq8 2n20
7 Jan 19
Departure of Directors or Certain Officers
4:30pm
8-K
elt7h9uabr3cphvortfu
18 Dec 18
Changes in Registrant's Certifying Accountant
5:00pm
8-K
431zkq2 58206k
17 Dec 18
Regulation FD Disclosure
7:05am
8-K
jc1wrztpc p4
17 Dec 18
Departure of Directors or Certain Officers
7:00am
8-K
l4q bz9bmath6q0nj
13 Nov 18
Other Events
7:15am
8-K
50kqc5n
24 Oct 18
Regulation FD Disclosure
7:00am
8-K
coxqog7
10 Oct 18
Regulation FD Disclosure
10:55am
8-K
zq6hurkptr0tg
9 Oct 18
Innovation Pharmaceuticals Secures Up to $10 Million in Additional Financing to Advance Clinical Pipeline
6:52am